Cenentry Biosciences Limited
13303149
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 25/03/2026
Due 08/04/2027
Industry
Officers
director · Since 30/03/2021
CHIEF EXECUTIVE
BRITISH · ENGLAND · Age 55
Also on 3 other boards
director · Since 20/06/2024
COMPANY DIRECTOR
GERMAN · ENGLAND · Age 53
Also on 2 other boards
Persons with Significant Control
Advent Life Sciences Llp
27, Fitzroy Square, London, W1T 6ES
Reg: Oc347034 · Register Of Companies For England And Wales · Limited Liability Partnership
Notified 21/06/2024
Former PSCs
Dr John Fraser Murray
Ceased 08/05/2024
CompanyRankvs 2042+ SIC 72110 peers42
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£20
Balance sheet strength
Cash
£93k
Cash in the bank
Net Current Assets
-£627k
Working capital
Current Assets
£219k
Current Liabilities
£847k
Debtors
£126k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 0.26 |
Derived from filed accounts. Not audited figures.